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Abstract
LMNA encodes both lamin A and C: major components of the nuclear lamina. Mutations in LMNA underlie a range of tissue-
specific degenerative diseases, including those that affect skeletal muscle, such as autosomal-Emery-Dreifuss muscular
dystrophy (A-EDMD) and limb girdle muscular dystrophy 1B. Here, we examine the morphology and transcriptional activity
of myonuclei, the structure of the myotendinous junction and the muscle contraction dynamics in the lmna-null mouse
model of A-EDMD. We found that there were fewer myonuclei in lmna-null mice, of which ,50% had morphological
abnormalities. Assaying transcriptional activity by examining acetylated histone H3 and PABPN1 levels indicated that there
was a lack of coordinated transcription between myonuclei lacking lamin A/C. Myonuclei with abnormal morphology and
transcriptional activity were distributed along the length of the myofibre, but accumulated at the myotendinous junction.
Indeed, in addition to the presence of abnormal myonuclei, the structure of the myotendinous junction was perturbed, with
disorganised sarcomeres and reduced interdigitation with the tendon, together with lipid and collagen deposition.
Functionally, muscle contraction became severely affected within weeks of birth, with specific force generation dropping as
low as ,65% and ,27% of control values in the extensor digitorum longus and soleus muscles respectively. These
observations illustrate the importance of lamin A/C for correct myonuclear function, which likely acts synergistically with
myotendinous junction disorganisation in the development of A-EDMD, and the consequential reduction in force
generation and muscle wasting.
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Introduction
Muscular dystrophies are a clinically heterogeneous group of
diseases characterised by progressive muscle weakness and wasting
of variable distribution and intensity [1]. They are subdivided into
groups with respect to the age of onset, and in accordance with the
primary muscle groups affected [1]. In many instances, a severe
cardiomyopathy is also present, sometimes in the absence of the
myopathy. The genes responsible for muscular dystrophies encode
proteins that form a disparate group, both in function and location
within the cell. For example, dystrophin is associated with the
cytoskeleton and its absence causes Duchenne muscular dystrophy
(DMD) [2], while emerin is located in the nuclear membrane and
its deficiency underlies X-linked Emery-Dreifuss muscular dystro-
phy (X-EDMD) [3]. Also located in the nuclear envelope are
lamin A and lamin C, mutations in which are responsible for
autosomal-Emery-Dreifuss muscular dystrophy (A-EDMD) [4]
and limb girdle muscular dystrophy (LGMD) 1B [5], in addition to
several other degenerative diseases [6].
The A-type (lamin A/C) and B-type (lamin B1 and B2) lamins
are type V intermediate filament proteins, which are major
components of the nuclear lamina: proteinaceous network
underling the inner nuclear membrane. Along with associated
nuclear envelope proteins such as emerin, nesprin isoforms and
SUN 1 and 2 (Sad1 and UNC84 domain-containing 1 and 2),
lamins contribute to maintaining the structural integrity of the cell
by cross-linking the nuclear envelope to the cytoskeletal network
via the link of nucleoskeleton and cytoskeleton complex (LINC)
[7]. All A-type lamins are encoded by LMNA by alternative
splicing, and mutations in this gene give rise to 16 tissue-specific
degenerative diseases collectively known as laminopathies [6].
Two non-mutually exclusive hypotheses have been proposed to
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lamin A/C as structural proteins in maintaining nuclear
architecture, since their absence results in sensitivity to mechanical
stress [8]. The second focuses on the role of the nuclear lamina as
a transcription platform, since nuclear lamins interact with a
variety of transcription factors such as c-Fos [9,10] and disruption
to such interactions lead to anomalous down-stream gene
expression [10].
The majority of laminopathies arise from dominant missense or
frameshift mutations (e.g. [4,11]), whereas mouse models to date,
need to be homozygous for a lmna mutation to display a phenotype
[12]. A patient reported to have a complete lack of LMNA function
had a severe phenotype and died at birth [13], so the lmna-null also
provides a useful model for A-EDMD [14]. Lmna
2/2 mice are
viable, but exhibit growth retardation from 2–3 weeks of age, and
stop growing after ,4 weeks. At 4–6 weeks of age, the mice
develop a rapidly progressive dilated cardiomyopathy (DCM),
with death usually around 8 weeks [15]. By 3–4 weeks, an
abnormal posture and gait develops, with many skeletal muscles
exhibiting dystrophic features, including the presence of centrally
located myonuclei, variability in myofibre diameter, signs of
atrophy and hyaline or flocculent cytoplasm. Muscle involvement
is not uniform however, with muscles of the head, tongue and
diaphragm largely unaffected in mutant mice [14]. As observed in
A-EDMD patients, myonuclei in lmna-null mice exhibit both
structural and antigen distribution abnormalities (e.g. LAP2, lamin
B, emerin). Lmna heterozygous mice do not show any overt signs of
growth retardation or dystrophic muscle, but develop atrio-
ventricular defects as early as 10 weeks of age [16].
Myonuclei are often analysed using muscle sections from
patients and mouse models. However, this technique does not
allow accurate enumeration of myonuclei per myofibre, analysis of
their distribution along a myofibre, or determination of the
proportion with abnormal morphology or function. To address
these limitations, we examined complete isolated myofibres from
mutant mice, allowing the ready scrutiny of all myonuclei and
satellite cells (the resident stem cells of adult muscle [17]). We
found fewer myonuclei present in myofibres from lmna-null mice,
many of which had morphological abnormalities, with variability
in size, shape and chromatin distribution. Assaying both epigenetic
modifications and the transcriptional machinery, revealed distinct
differences in the transcriptional activity between myonuclei
within a myofibre. Myonuclei with abnormal morphology and
decreased transcriptional activity were distributed along the length
of the myofibre, but were particularly evident at the myotendinous
junction. Indeed, the structure of the myotendinous junction was
generally disturbed, with less inter-digitations between myofibre
and tendon, disorganised sarcomeres and collagen/lipid deposi-
tion. Investigation of muscle contraction dynamics showed that
function in lmna
2/2 muscles was dramatically impaired at 4–5
weeks of age, as shown by the reduction in muscle specific force.
Thus there are clear structural myofibre abnormalities and
deregulation of gene expression between individual myonuclei
distributed throughout a myofibre, which likely contribute to the
marked decline in muscle contractile ability observed.
Materials and Methods
Ethics statement
Mice were bred, and experimental procedures carried out, in
accordance with British law under the provisions of the Animals
(Scientific Procedures) Act 1986, under project license PPL0672,
as approved by the King’s College London Ethical Review Process
committee.
Mouse models
A heterozygous breeding colony of mice with a null allele of
lmna [14] was established to obtain lmna
2/2, lmna
2/+ and lmna
+/+
(wild-type), from mice supplied by Carlos Lopez-Otin (University
of Oviedo, Spain). Mice were genotyped by PCR on genomic
DNA obtained from the tail using the Manual ArchivePure DNA
Purification Kit (5Prime, Gaithersburg, MD, USA) with the
following primers:
Forward: 59 CGATGAAGAGGGAAAGTTCG 39
Mutant-specific reverse: 59 GCCGAATATCATGGTGGAAA
39
Wild-type-specific reverse: 59 CCATGGACTGGTCCTGAA-
GT 39
Cycling parameters were 95uC/30 s, 60uC/30 s, 72uC/60 s for
35 cycles. PCR produced a 750 bp amplicon from the mutated
allele and a 520 bp amplicon from wild-type.
Myofibre isolation
Mice aged 4–6 weeks were killed by cervical dislocation and the
extensor digitorum longus (EDL) and/or soleus muscles removed
from the hind limb. Muscles were incubated in 0.2% collagenase
Type I/DMEM with 400 mM L-Glutamine (Sigma, Dorset, UK)
and 1% (v/v) penicillin/streptomycin solution (Sigma, Dorset,
UK) for 1.5 hour at 37uC. Collagenase was then inactivated and
individual myofibres liberated by trituration, as described in detail
elsewhere [18,19]. Selected myofibres were free of capillaries or
residual connective tissue. 15 or more isolated myofibres from at
least 3 mice per genotype were analyzed for each experiment.
In order to determine the total number of myonuclei, myofibres
were immunostained for Pax7 (to identify satellite cells, [20]) and
4,6-diamidino-2-phenylindole (DAPI) to visualize all nuclei (both
myonuclei and satellite cells). EDL myofibres were isolated from 5
wild-type, 5 lmna
2/+ and 7 lmna
2/2 age-matched mice and
multiple myofibres analyzed per type.
Antibodies and immunostaining
Myofibres were fixed in 4% paraformaldehyde/PBS for 10
minutes, permeabilised with 0.5% (v/v) Triton X-100 in PBS and
then blocked using 10% (v/v) goat serum and 10% (v/v) swine
serum (DakoCytomation, Ely, UK) in PBS.
Primary antibodies used were monoclonal mouse anti-Pax7
(Developmental Studies Hybridoma Bank, Iowa, USA), polyclonal
rabbit anti-acetylated (K9 and K14) -Histone H3 (Millipore,
Watford, UK) and monoclonal rabbit anti-PABPN1 (clone
EP3000Y, Epitomics, CA, USA). Primary antibodies were
visualized with species-specific highly adsorbed Alexafluor-conju-
gated secondary antibodies (Cell Signalling, MA, USA) before
mounting on slides with VECTASHIELD Mounting Medium
containing 1.5 mg/ml of DAPI (Vector Laboratories, Peterbor-
ough, UK).
Images were acquired using a LSM 5 EXCITER confocal
microscope equipped with a water immersion LD C-Apochromat
40x/1.1 W Corr objective with acquisition software ZEN 2007
LSM (Zeiss), or a Zeiss Axiophot 200 M microscope with a
Charge-Coupled Device (Zeiss AxioCam HRm). Images were
adjusted globally for brightness and contrast and assembled into
figures using Adobe Photoshop CS.
Transmission electron microscopy
Six EDL and soleus muscles from age-matched (3561 days)
wild-type (n=3) and lmna-null (n=3) mice were fixed in 2.5%
phosphate buffered glutaraldehyde (pH 7.3, 0.1 M) for 4 hours at
4uC. The samples were then washed and post-fixed in 1% OsO4 in
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PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e166510.1 M Milloning’s phosphate buffer pH 7.3 for 1.5 hour at 4uC.
Dehydration in ascending grades of ethanol and resin impregna-
tion at room temperature occurred prior to embedding in epoxy
resin TAAB Premix Medium Resin Kit (TAAB Laboratories
Equipment Limited, Berks, UK). Ultra-thin sections (,80 nm
thick) were stained with a saturated solution of uranyl acetate and
0.17% lead citrate in 0.1 N sodium hydroxide. At least 3 sections
per muscle per mouse were analyzed and viewed at 75 Kv in a
Hitachi H7600 Transmission Electron Microscope.
Image analysis
Image J software (http://rsb.info.nih.gov/ij) was used to
measure the length, width, area and perimeter of myonuclei on
confocal images from multiple EDL myofibres. Images of
myonuclei from soleus muscles acquired by TEM were also
analyzed with Image J software to measure length and width of
nuclei, together with the amount of highly condensed nuclear
chromatin. TEM images from 22 myonuclei from 3 wild-type, and
32 myonuclei from 3 lmna-null mice (6 muscles per genotype) were
analyzed.
Muscle mechanical force evaluation
Three EDL and three soleus muscles were dissected from wild-
type, lmna
2/+ and lmna
2/2mice aged 4 and 5 weeks (3 mice per
genotype per age) and their contractile properties were measured
in an experimental chamber filled with an oxygenated Krebs-
Henseleit solution at 25uC. The chamber was perfused continu-
ously with 95% O2/5% CO2. One end of the muscle was attached
to the force transducer (300B, Aurora Scientific Inc., Ontario,
Canada) and the other end to a fixed steel hook. The muscles were
stimulated by an electric field generated between two platinum
electrodes placed longitudinally on either side of the muscle.
Square wave pulses 0.2 ms in duration were generated by a
stimulator to produce a maximum isometric twitch force. Muscles
were adjusted to the optimum length for the development of
maximum isometric tetanic contraction. After the experiment, the
muscle was blotted dry and weighed, and the mean cross-sectional
area was calculated assuming a muscle density of 1.06 mg mm
23
[21]. The muscle specific force at optimum length was expressed
as the maximum isometric tetanic force per unit cross-sectional
area of muscle.
All statistics are given as mean 6 SEM. Unpaired t-test was
used, where p,0.05 (two-tailed) was considered statistically
significant.
Results
Myofibres from lmna-null mice have fewer myonuclei
and satellite cells
We used the EDL and soleus muscles from the crural hind limb,
since lower leg muscles are among those more severely affected in
human EDMD patients [22]. In addition, the EDL is mainly
composed of fast type IIx and IIb fibre types, while soleus
comprises slow type I and fast type IIa fibres [23,24], allowing
assessment of the major extrafusal muscle fibre types in mouse.
To first determine if lmna-null mice had as many myonuclei and
satellite cells as controls, myofibres were isolated from the EDL
muscle of lmna
2/2, lmna
2/+ and lmna
+/+ (wild-type) mice and
immunostained for Pax7 to identify satellite cells, then counter-
stained with DAPI to distinguish myonuclei [25]. EDL myofibres
from lmna
2/2 mice contained significantly fewer myonuclei
(201.163.8 versus 289.567.7 in wild-type) and satellite cells
(3.360.2 versus 4.660.3 in wild-type) than either lmna
2/+ or wild-
type; which had similar numbers (Table 1). Interestingly, the ratio
of satellite cell number to total nuclei number per myofibre,
remained constant at ,1.660.1 for each genotype (Table 1).
Myonuclear morphology is abnormal in lmna-null mice
To next examine the morphology and chromatin distribution in
myonuclei, myofibres were isolated from both the EDL and soleus
muscles of lmna
2/2, lmna
2/+ and lmna
+/+ (wild-type) mice, together
with those from mdx mice (a model of DMD [26,27]). In both
lmna
2/+ and wild-type mice, 98% of myonuclei were of a regular
oval shape, similar in size and evenly distributed along the entire
length of the myofibre (Figure 1a and 1d). The long and short axes
of myonuclei in wild-type EDL myofibres were 13.160.2 mm and
6.860.1 mm respectively, and the length/width ratio was 260.1.
Their contour ratio (4p area/perimeter
2 - a measure of how close
to round a structure is) was 0.860.01. By contrast, myonuclei in
lmna
2/2 mice varied greatly in size, were irregularly shaped, and
often were unusually elongated along the long axis of the myofibre
(Figure 1b and 1e). The long and short axes of myonuclei of lmna-
null EDL myofibres were 16.161.2 mm and 4.660.3 mm,
respectively, and their length/width ratio was 4.560.7 (p,0.01
compared to wild-type) with a contour ratio of 0.660.02. All lmna-
null myofibres analyzed had regions containing abnormal
myonuclei and DAPI-stained fragments, but there was no
evidence of myofibre branching or organized chains of centrally
located myonuclei, indicative of muscle regeneration (Figure 1b
and 1e). While myofibres from the soleus of lmna-null mice clearly
contained many myonuclei with an abnormal morphology
(Figure 1e), it was often difficult to delimit individual myonuclei
to get a representative sample for detailed measurements, as
performed for EDL myofibres. There was also a higher variability
in EDL and soleus myofibre length and diameter between lmna
2/2
mice compared to those from either lmna
2/+ or wild-type (data not
shown).
Condensed chromatin amount and distribution are
altered in myonuclei lacking lamin A/C
DAPI binds to double-stranded DNA and is routinely used to
examine condensed chromatin (heterochromatin) distribution
Table 1. Total nuclei and satellite cells in EDL myofibres from lmna-null mice.
Total nuclei per EDL myofibre Satellite cells per EDL myofibre Satellite cell/total nuclei ratio
Wild-type (n=67) 289.567.7 4.660.3 1.660.1
lmna
2/+ (n=68) 268.965.4 4.460.6 1.660.1
lmna
2/2 (n=97) 201.163.8
* 3.360.2
* 1.660.1
20 myofibres from 3 mice per genotype were analyzed. Total number of myofibres analyzed is indicated in parenthesis. Values are mean 6 SEM. An asterisk denotes
p,0.01 compared to wild-type using Student’s t-test.
doi:10.1371/journal.pone.0016651.t001
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was similar in all myonuclei, with strongly stained chromatin
regions regularly distributed throughout the myonucleus
(Figure 1a and 1d). By contrast, lmna-null mice exhibit differential
DAPI staining between myonuclei, with variable amounts of
irregularly distributed, and highly condensed, chromatin
(Figure 1b and 1e).
To increase resolution, we used Transmission Electron
Microscopy (TEM) on ultra-thin sections of soleus muscle from
wild-type lmna
+/+ and lmna-null mice (Figure 1g and 1h). The ratio
of nuclear length to width showed that myonuclei from soleus were
significantly more elongated (7.160.8 compared to 2.760.2 -
Table 2). Myonuclei from wild-type mice possessed a condensed
chromatin layer directly inside the nuclear membrane. In addition,
there were one or more round central clumps of condensed
chromatin, indicative of nucleoli, together with occasional smaller
accumulations (Figure 1g). In ,85% of lmna-null myonuclei
analyzed by TEM, such highly organized chromatin distribution
was lost (Figure 1h). Furthermore, it was no longer completely
juxtaposed to the inner nuclear membrane. Such a distribution of
heterochromatin can be a sign of DNA fragmentation and a key
feature of the early stages of apoptosis [29]. Measuring the area of
the myonucleus occupied by electron dense chromatin, revealed
that it was significantly higher in lmna
2/2 mice (63.462.2% versus
49.462.1% in wild-type - Table 2). Moreover, ,24% of the
analyzed myonuclei contained vacuoles (labelled with an asterisk
in Figure 1h). Interestingly, myofibres often displayed disorganized
sarcomeres in close proximity to the most affected myonuclei
(Figure 1h - residual sarcomeres in an highly disorganized area are
shown in the red box).
Figure 1. Myonuclear morphology is abnormal in lmna-null mice. DAPI staining of representative EDL and soleus myofibres from wild-type
(WT) lmna
+/+mice show that myonuclei are evenly distributed and have similar shape, size and heterochromatin content (a and d). By contrast,
myonuclei in lmna
2/2 myofibres are unevenly distributed, with variable size and shape, and heterogeneous chromatin content and distribution (b
and e). Myofibres isolated from the mdx mouse model of DMD contain myonuclei of a more regular size, shape and heterochromatin organization (c
and f). Unlike in lmna
2/2 myofibres, myonuclei in mdx mice are often located in a chain in the centre of the myofibre, indicative of a recent
regenerative event (c and f). Representative TEM images of longitudinal sections of soleus muscle from wild-type lmna
+/+ (g) and lmna
2/2 (h) mice.
WT myonuclei (thin red arrows) are regularly shaped, and have an even layer of highly condensed chromatin around the nuclear rim, in addition to
centrally located condensations (g). Myonuclei (thin red arrows) from lmna null mice are irregularly shaped and have disorganized chromatin
throughout with occasional vacuoles (h - red *). A thick red arrow indicates an abnormally elongated myonucleus. Note connective tissue between
myofibres and the disruption of the sarcomeric arrangements near the abnormal myonuclei (red open square). Scale bar for (a–f)i s5 0mm and 10 mm
for (g and h).
doi:10.1371/journal.pone.0016651.g001
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muscle
To determine whether our observations on the myonuclei of
lmna-null myofibres were a general feature of dystrophic muscle,
or specific to the dystrophic phenotype associated with a lack of
lamin A/C, we also isolated myofibres from the mdx mouse model
of DMD [26,27]. Myofibres from EDL and soleus of mdx mice
had highly variable lengths and diameters (data not shown), more
so than lmna
2/2 myofibres, and were occasionally split and
branched (Figure 1c and 1f). However, myonuclei had a regular
shape and size, and were evenly distributed, although there were
many areas containing chains of centrally located myonuclei
(Figure 1c and 1f), indicative of muscle regeneration. Moreover,
DAPI staining of mdx myonuclei revealed an overtly normal
chromatin distribution.
Abnormal myonuclei accumulate at the myotendinous
junction. The myotendinous junction is a specialised
structure where the muscle connects to the tendon, and is the
principal site of longitudinal force transmission across the
muscle cell membrane [30,31]. Myonuclei at the myotendinous
junction of wild-type lmna
+/+ myofibres were indistinguishable
f r o mt h o s el o c a t e de l s e w h e r ea l o n gt h ef i b r e( F i g u r e2 aa n dd ) .
By contrast, many myonuclei at the myotendinous junction of
lmna
2/2 mice were clearly structurally abnormal, with aberrant
chromatin accumulations (Figure 2b and e). Measuring the 10
myonuclei closest to the myotendinous junction (from at least 5
myotendinous junctions from 5 mice per genotype) we found
that the average length and width of wild-type myonuclei were
11.160.2 mma n d6 . 1 60.1 mm, respectively; whereas the
average length and width of the 10 lmna-null myonuclei closest
to the myotendinous junction were 16.560.9 mma n d
4.760.2 mm. Thus, the length/width ratio for lmna-null
myotendinous junction myonuclei was 4.060.3, significantly
different (p,0.01) from the wild-type ratio of 1.960.1. The
average contour ratio was 0.660.02 for lmna-null myonuclei at
the myotendinous junction versus 0.860.01 for wild-type
(p,0.01). Importantly, ,85% of myofibres from lmna-null
mice had myotendinous junctions at which myonuclei were
clustered (Figure 2b and e). Again, we examined whether this
was a common feature of muscular dystrophy. Myotendinous
junctions of mdx myofibres did not accumulate myonuclei, and
when present, chains of centrally located myonuclei often
remained in register until the extremity of the myotendinous
junction (Figure 2c and f).
Table 2. Morphological and chromatin content alterations in soleus myonuclei of lmna-null mice.
Length (mm) Width (mm) Length/Width ratio
Percentage of nuclear volume occupied by
condensed chromatin
Wild-type myonuclei
(n=22)
8.460.5 3.460.3 2.760.2 49.462.1%
lmna-null myonuclei
(n=32)
12.561.1 2.260.2 7.160.8
* 63.462.2%
*
7 myonuclei from 3 mice per genotype were analyzed by TEM. Total number of myonuclei analyzed is indicated in parenthesis. Values are mean 6 SEM. An asterisk
denotes p,0.01 compared to WT using Student’s t-test.
doi:10.1371/journal.pone.0016651.t002
Figure 2. Myonuclei cluster at the myotendinous junctions of lmna
2/2 myofibres. DAPI staining at the myotendinous junction from wild-
type (WT) lmna
+/+ EDL and soleus myofibres show that myonuclei are evenly distributed, with similar shape, size and chromatin organization (a and
d). Myonuclei tend to cluster at the myotendinous junction from lmna
2/2 mice, and are unevenly distributed with varying sizes, shapes and
condensed chromatin content (b and e). Myonuclei of the myotendinous junction from mdx mice have an overtly normal morphology, although
often in centrally located chains that continue to the end of the myofibre (c and f). Scale bar 50 mm.
doi:10.1371/journal.pone.0016651.g002
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lmna-null mice
Abnormal chromatin distribution in the lmna-null mice may
indicate compromised transcription. Histones can be epigeneti-
cally modified by site-specific combinations of phosphorylation,
acetylation and methylation, which correlate with specific
biological readouts, such as transcriptional activation or repres-
sion, chromatin remodelling or stabilization [32]. In particular,
acetylation of histones H3 and H4 positively correlates with active
gene transcription [33,34].
As an assessment of transcriptional activity of myonuclei, we
immunostained for acetylated histone H3 (K9 and K14). Largely
homogeneous immunostaining of acetyl-H3 was observed in
myonuclei from freshly isolated EDL myofibres of wild-type
lmna
+/+ mice, indicating coordinated transcriptional activity
(Figure 3a-c). By contrast, myonuclei in lmna-null myofibres had
heterogeneous levels of histone H3 acetylation, with some
myonuclei virtually unstained, while others exhibited normal, or
even apparently increased, levels of immunostaining. These
varying levels of histone H3 acetylation indicate that transcrip-
tional activity differs between individual, often adjacent, myonu-
clei (Figure 3d–f). Approximately 50% of myonuclei were clearly
misshapen in EDL lmna-null myofibres, compared to ,2% for
those of wild-type. While severely misshapen myonuclei were most
Figure 3. Variable transcriptional activity and mRNA processing between myonuclei of lmna-null mice. Representative images of wild-
type (WT) lmna
+/+ EDL myofibres, immunostained for acetyl-histone H3 (red) and counter-stained with DAPI (white), with merged images (a–c).
Myonuclei in WT myofibres have near uniform acetyl-histone H3 immunostaining, suggesting similar transcriptional activity. By contrast,
immunostaining of lmna
2/2 EDL myofibres showed that myonuclei clearly have varying acetyl-histone H3 levels, indicating heterogeneous
transcriptional activity, with some immunostaining at near background levels (d–f - arrows) while others appear hyperacetylated (d–f - arrowhead).
WT myonuclei also show virtually homogeneous PABPN1 immunostaining (g–i), while in many myonuclei of lmna
2/2 EDL, PABPN1 is either reduced,
or absent (j–l - arrows). Scale bar 50 mm.
doi:10.1371/journal.pone.0016651.g003
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staining (,26% of the 50% misshapen, so ,13% of total nuclei
were hypoacetylated), there were also a significant number of
overtly morphologically normal myonuclei that were hypoacety-
lated (,7%, i.e. ,3.5% of total). Western Blot analysis of EDL
myofibres showed that global acetyl-histone H3 levels were
significantly increased (,2.5 fold) in lmna-null myofibres compared
to wild-type (data not shown).
Next, we assessed the state of the transcriptional machinery:
poly(A) binding protein nuclear 1 (PABPN1) is an abundant
nuclear protein that is part of the polyadenylation complex and
integral for completion of messenger RNA maturation [35].
Myonuclear PABPN1 immunostaining was virtually homogeneous
in wild-type lmna
+/+ myofibres (Figure 3g–i), whereas it varied
greatly between individual, often adjacent, myonuclei in lmna-null
myofibres (Figure 3j–l). Together with the epigenetic changes
indicated by variable histone acetylation, the distribution of
PABPN1 further indicates that gene expression is deregulated in
the absence of lamin A/C. The wide variation in transcriptional
activity both between individual myonuclei and myofibres is
consistent with the transcriptional deregulation observed in patient
muscle [10]. Unfortunately, we were unable to co-immunostain
Figure 4. Transcriptional activity and mRNA processing are often impaired in myonuclei at the myotendinous junctions of lmna-null
mice. Representative images of wild-type (WT) lmna
+/+ EDL myofibres immunostained for acetyl-histone H3 (red) and counter-stained with DAPI
(white), with merged images (a–c). Myonuclei at the myotendinous junction (MTJ) in WT myofibres have near homogeneous acetyl-histone H3
immunostaining, as observed along the myofibre, indicating similar levels of transcriptional activity. By contrast, immunostaining of lmna
2/2 EDL
myofibres revealed that myonuclei at the myotendinous junctions clearly had varying acetyl-histone H3 levels, indicating heterogeneous
transcriptional activity, ranging from virtually inactive (background levels – arrow in d–f), to hyperacetylated, myonuclei (d–f). WT myonuclei also
exhibit regular and homogeneous PABPN1 immunostaining at the myotendinous junction (g–i). In myonuclei at the myotendinous junctions of
lmna
2/2 EDL however, varying PABPN1 levels are observed, with many being virtually unstained (j–l - arrows), indicating an impairment of mRNA
processing and maturation. Scale bar 50 mm.
doi:10.1371/journal.pone.0016651.g004
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raised in rabbit, and were of the same isotype.
Consistent with myonuclei distributed along the myofibre,
myonuclei at the myotendinous junctions in wild-type lmna
+/+
mice had near homogeneous immunostaining for acetyl-H3
(Figure 4a–c) and PABPN1 (Figure 4g–i). However, myonuclei
at the myotendinous junctions of lmna-null mice exhibited
heterogeneous immunostaining, with a majority being hypoacety-
lated (Figure 4d–f) or having a marked reduction in PABPN1
protein levels (Figure 4j–l).
The structure of the myotendinous junction is severely
perturbed in lmna-null mice
Examining the ultrastructure of both EDL and soleus muscles
using TEM, we found that the myotendinous junctions from wild-
type lmna
+/+ mice had myonuclei with normal morphology, a
regular sarcomeric organization, and marked interdigitations
between the myofibre and tendon (Figure 5a–c and 5g–i). In
lmna
2/2 mice however, ,90% of myotendinous junctions in EDL
(Figure 5d–f) and all examined in soleus (Figure 5j–l) exhibited
structural abnormalities including: myofibril loss in the proximity of
Figure 5. Myotendinous junction structure is abnormal in lmna
2/2 mice. Representative TEM images of longitudinal sections of
myotendinous junction (MTJ) from EDL (a–c) and soleus (g–i) myofibres of wild-type (WT) lmna
+/+ mice. Myonuclei (red arrows) and sarcomere
organisation appear normal. Note the extensive inter-digitations between the myofibre and tendon. TEM images of longitudinal sections of
myotendinous junctions from EDL (d–f) and soleus (j–l) myofibres from lmna
2/2 mice. Myonuclei with abnormal shape, size and chromatin
organization are evident (red arrows). There is a lack of inter-digitations, abnormal connective tissue (C in panel d) and fat accumulations (asterix in
panel f) and sarcomeric disorganisation (boxed area in panel f). Myotendinous junctions in soleus muscle are particularly badly affected (j–l). The
tissue architecture in (l) is so disrupted that the muscle region (M) and the connective tissue region (C) are barely distinguishable. Scale bar in each
image equals 10 mm.
doi:10.1371/journal.pone.0016651.g005
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increased fibrotic and adipose deposition (,83% EDL and ,92%
soleus - Table 3); reduced and irregular interdigitation (,75% EDL
and ,82% soleus - Table 3) and presence of vacuoles (,42% EDL
and ,63% soleus - Table 3). Disorganised sarcomeres were
regularly observed at the myotendinous junction, which was more
pronounced in the proximity of abnormal myonuclei. Myotendi-
nous junctions in soleus were more disrupted than those of the EDL
(Table 3), often showing a complete loss of the organized transition
between muscle and tendon (as illustrated in Figure 5l).
Lmna-null mice have delayed growth and decline in
weight after a month of age
Lmna-null mice show post-natal growth retardation with weight
,50% of their wild-type littermates at 28 days of age [14].
Similarly, we found that wild-type and lmna
2/+ mice were
indistinguishable 24 days after birth, whereas lmna
2/2 mice were
approximately half their size (6.361.2 g). Both wild-type and
lmna
2/+ mice increased their body mass by $0.5 g per day,
whereas lmna-null body mass increased by only ,0.2 g per day,
and reached a maximum by day 29 to 32, after which it declined
by ,0.3 g per day. By day 37 lmna
2/2 mice were less than one
third the size of wild-type and heterozygous littermates (6.360.9
versus 20.660.7 and 20.260.9 g respectively). Generally, between
day 34 and 37 lmna-null mice stopped moving and were sacrificed.
Lmna-null muscles generate less force
To examine if the structural and transcriptional changes we
identified correlate with compromised muscle function, we
measured force generation in EDL and soleus muscles at 4 and
5 weeks of age. Muscle contractile properties were tested in terms
of muscle specific force, which was measured at 25uC and
calculated by dividing maximum isometric tetanic force by mean
muscle cross-sectional area. Three EDL and three soleus muscles
removed from wild-type lmna
+/+, lmna
2/+ and lmna
2/2 mice (n=3
per age group) aged 4 weeks (mice still growing and active) and
compared to those from 5 weeks old mice (mice no longer
growing, often barely active). EDL and soleus muscle mass was
reduced in lmna-null mice, in accordance with the reduced total
body mass. Moreover, the muscle mass actually declined between
4 and 5 weeks, with EDL and soleus of lmna-nulls ,80% of wild-
type and heterozygous at 4 weeks, and ,35% by 5 weeks.
Soleus muscles from 4 week old lmna
2/2 mice showed a
significant reduction in force generation, with muscle specific force
only ,70% of controls (Figure 6a). The muscle specific force in
both EDL and soleus from 5 week old lmna
2/2 mice was
significantly reduced. Mean P0 of soleus muscles was only ,27%
of age-matched controls, while it was ,65% for the EDL
(Figure 6a). There was no reduction in the force generation ability
of muscles from lmna
2/+ mice at either age.
Importantly, the reduction in muscle specific force of lmna-null
muscle was not accompanied by changes in force generation
profile, with the soleus muscle still showing the force generation
profile typical of a slow muscle and the EDL, that of a fast muscle
(Figure 6b).
Discussion
EDMD and LGMD1B are characterised by muscle weakness
and wasting, with abnormal myonuclear morphology. However it
is unclear how many myonuclei are actually affected, with
estimates ranging from 10%–90% for those having morphological
and/or chromatin irregularities [36–38]. These observations have
been largely made using muscle sections however, which makes it
is extremely difficult, if not completely impractical, to examine all
myonuclei in a given myofibre: the basic functional unit of skeletal
muscle. Furthermore, three dimensional myonuclear morphology
and distribution are also not easily analysed. These limitations
however, can be overcome by isolating entire myofibres where
possible.
Myofibres from the lmna-null mouse model of A-EDMD varied
in size, but were generally smaller than controls, containing ,30%
fewer myonuclei. Importantly, each myofibre contained myonuclei
with abnormal morphology and chromatin distribution, which
equated to ,50% of the entire population in the EDL. These
pathological hallmarks were even more widespread in the soleus,
where altered chromatin distribution and increased compacted
and clumped chromatin were evident using TEM. Interestingly,
chains of centrally located myonuclei were not seen in adult lmna-
null mice, while this hallmark of muscle regeneration is apparent
in many myofibres of mdx mice [26].
Our findings are consistent with reports of the morphology and
chromatin distribution in myonuclei from other skeletal muscles,
cardiomyocytes and embryonic fibroblasts in lmna-null mice
[15,39] and in patients, where an overall decrease of condensed
heterochromatin, focal loss of chromatin and increased clumping
away from the myonuclear rim have been described [36–38,40].
Similarly, ,10% of myonuclei in the H222P mouse model of
EDMD (containing a pathogenic point mutation at residue 222 in
the lmna gene that causes familial A-EDMD and dilated
cardiomyopathy in man) exhibit structural abnormalities and
heterochromatin redistribution when examined using muscle
sections [41]. Since similar changes occur in cardiomyocytes of
syne1 null mouse (lacking nesprin 1) [42], this indicates that
disruption of different components of the LINC complex cause a
common phenotype.
It is well established that lamin A/C have a crucial role in
chromatin organization [43,44] and gene transcription [45]. To
understand how such morphological changes affect myonuclear
function, we examined the transcriptional state of myonuclei by
assessing both epigenetic modifications indicative of an active
Table 3. Quantification of myotendinous junction abnormalities in lmna-null mice.
Myofibril loss Increased fibrosis Decreased interdigitation Vacuoles
Wild-type EDL myotendinous junction 2/33 (6.1%) 1/33 (3.0%) 2/33 (6.1%) 2/33 (6.1%)
lmna-null EDL myotendinous junction 22/24 (91.7%) 20/24 (83.3%) 18/24 (75.0%) 10/24 (41.7%)
Wild-type soleus myotendinous junction 2/35 (5.7%) 0/35 (0%) 1/35 (2.9%) 2/35 (5.7%)
lmna-null soleus myotendinous junction 38/38 (100%) 35/38 (92.1%) 31/38 (81.6%) 24/38 (63.1)
TEM images of 33 wild-type EDL myotendinous junctions, 24 lmna-null EDL myotendinous junctions, 35 wild-type soleus myotendinous junctions and 38 lmna-null
soleus myotendinous junctions were acquired from a minimum of 7 myotendinous junctions from 3 mice per genotype.
doi:10.1371/journal.pone.0016651.t003
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PABPN1, a component of the transcriptional machinery. PABPN1
is an abundant nuclear protein that binds the poly(A) tail of pre-
mRNA and is part of the polyadenylation complex through
interactions with poly(A) polymerase and cleavage and adenylation
specificity factor. PABPN1 stimulates the polymerization of the tail
by poly(A) polymerase, thus controlling the length of the poly(A)
tail [35].
Absence of lamin A/C caused heterogeneous levels of both
acetylated histone H3 and PABPN1 between myonuclei,
indicating that transcriptional activity varied and revealing a
lack of coordinated transcriptional control. Importantly, altered
acetyl-histone H3 patterns were not always linked to aberrant
morphology, with many apparently ‘normal’ myonuclei being
completely hypoacetylated, and so presumably transcriptionally
inactive. Assessing global acetyl-histone H3 levels by Western
blot, we found a significant increase (,2.5 fold) in lmna-null
myofibres compared to wild-type. Histone H3 hyperacetylated
fibres have also been observed in the tibialis anterior muscles of
lmna-null mice [46]. Therefore, the marked reduction/absence of
acetyl-histone H3 from a significant number of lmna-null
myonuclei was more than counterbalanced by the relative
Figure 6. Force generation is impaired in EDL and soleus muscles lacking lamin A/C. Muscle specific force produced by EDL (left panel)
and soleus (right panel) from wild-type (WT) lmna
+/+, lmna
2/2 and lmna
2/+ mice at 4 (white bars) and 5 (grey bars) weeks of age (a). Generation of
isometric tetanic force at optimim length by EDL and soleus from WT (—), lmna
2/+ (---) and lmna
2/2 (????) mice at 4 and 5 weeks of age (b). 3 muscles
from 3 mice per genotype per age were analyzed. Values are mean 6 SEM from three muscles. An asterisk denotes significance level using Student’s
t-test. *** p,0.001; * p,0.05;
ns p.0.05. Each value is compared with that of age-matched WT. The muscle specific force was also significantly
different for soleus muscles from lmna
2/2 mice between 4 and 5 weeks of age.
doi:10.1371/journal.pone.0016651.g006
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have been reported in myoblasts from A-EDMD patients
carrying either the R377H or R545C mutations [47,48], and
also occur following over-expression of the A-EDMD-causing
lamin A mutation R453W in C2 myoblasts [49]. Epigenetic
modifications are also found in fibroblasts from patients with the
premature aging disorder Hutchinson-Gilford progeria syndrome
[50], indicating that it may be a feature common to lamino-
pathies in general.
Lamin A/C not only binds chromatin and chromatin-associated
proteins [51,52], but can also associate with specific transcription
factors. For example, lamin A/C-mediated c-Fos sequestration at
the nuclear envelope and their interactions with ERK1/2, regulate
AP1 (Activating Protein 1) activity [9,53]. Thus regulation of
transcription mediated by A-type lamins can operate through at
least two inter-dependent mechanisms: firstly, through direct
binding of chromatin and chromatin-associated proteins, the
nuclear lamina can regulate chromatin positioning, promote
silencing at the periphery and induce global epigenetic changes;
secondly, by interaction with specific transcription factors and
signal transduction components, it can mediate the fine tuning of
tissue specific transcriptional programs and signalling pathways.
Indeed, general disturbances of the transcriptome in A-EDMD
and X-EDMD patient muscle have been reported using micro-
arrays [10], with a number of signal transduction pathways being
affected including Rb1/MyoD, MAPK/ERK, PI3K/Akt and
TGFb/Smad [10,54–57].
A striking finding was that myonuclei of lmna-null mice not only
clustered at the myotendinous junction, as previously reported
[58], but were consistently abnormal, with irregular shape,
chromatin distribution and importantly, reduced transcriptional
activity. Thus, this myonuclear clustering may be a response to the
compromised transcriptional activity of many myonuclei, and the
necessity to reduce the average myonuclear domain. There were
also more widespread structural defects at the myotendinous
junction, including increased fibrotic and adipose tissue, loss of
myofibrils and sarcomeric organization, the presence of vacuoles
in the cytoplasm and a lack of interdigitation between the muscle
fibre and tendon. EDMD is unique amongst muscular dystrophies
in that contractures develop early, notably in the Achilles tendons
and elbow, prior to any clinically significant muscle weakness.
Since myotendinous junctions are the main point of force
transmission between fibre and tendon, and the primary site of
lesion in many muscle tears [30,59,60], we speculate that defects at
the myotendinous junction could be in part responsible for the
functional failure contributing to joint contractures. In particular,
the lack of interdigitations and cytoplasmic splitting could
significantly reduce the area over which the transmitted force is
distributed [59,60], and accumulation of connective tissue on the
tendon side could cause stiffness and, ultimately, contractures.
Myofibres from mdx mice have blunt myotendinous junctions,
lacking the digit-like processes typical of wild-type myofibres [61],
but we did not observe myonuclear clustering at the myotendinous
junction in mdx. Thus, while these two mouse models share some
pathophysiological changes at the myotendinous junction, myo-
nuclei clustering is a specific feature of lamin A/C-deficient
muscles. Interestingly, myonuclear positioning at the neuromus-
cular junction is also affected in lmna-null mice, and myonuclei also
showed hyperacetylation of histone H3 lysine 9, a hallmark of
muscle denervation [46].
The myotendinous junction is the essential force-transmitting
component of the musculoskeletal system, and so their perturbed
structure could affect force generation in muscles. While muscle
specific force was reduced in both the EDL and soleus by 5 weeks
of age, the soleus was more precociously and severely affected than
EDL. This may correlate with the more widespread and greater
disturbances in myonuclei and structure of the myotendinous
junction in lmna-null soleus muscle. A drop in twitch and tetanic
force generation in soleus and diaphragm muscle from lmna-null
was previously reported [62]. However, soleus and diaphragm
both consist of slow and fast muscle fibre types, and so we
compared soleus with the EDL, which is almost exclusively
composed of fast muscle fibre types [23]. It is important to note
that the reduction in force generation was not accompanied by a
change in the overall fibre type distribution, with the soleus still
generating a typical tetanic force curve of a slow muscle and the
EDL, that of a fast muscle. Although other factors probably
contribute, such as the variable transcriptional status, the
perturbed myotendinous junction structure is likely to be a
significant factor.
In conclusion, analyzing myofibres from the lmna-null mouse
model of A-EDMD revealed that compromised myonuclear
structure and transcriptional deregulation were widespread.
Abnormal myonuclei accumulate at the myotendinous junction,
the structure of which is clearly perturbed. Combined, these
changes presumably result in the rapid decline in force generation.
Therefore, myonuclear and myotendinous junction dysfunction
may act synergistically to produce the dystrophic phenotype in A-
EDMD.
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